$8.61 -0.31 (-3.48%)
11/27/2009 1:00 PM

Nektar Therapeutics (NKTR)

CAPS Rating: 3 out of 5

A biopharmaceutical company which develops breakthrough products that make a difference in patients' lives. It creates differentiated, innovative products by applying its platform technologies to established or novel medicines.

Featured Broker Partners